The SEC obtained a final judgment against Joseph Geromini on May 15, 2026, concluding a years-long enforcement action against the former chief operating officer of a Philadelphia medical device startup. Geromini was accused of stealing more than $200,000 from investors and lying about how their money would be used.
What Geromini allegedly did
According to SEC Litigation Release LR-26555, Geromini served as COO of Group K Diagnostics, a company now operating as HueDx. Between August 2018 and May 2019, he raised investor capital while allegedly using company funds for personal expenses. The SEC says he disseminated false offering documents and financial models that failed to disclose his ongoing theft.
The complaint describes a series of materially false statements. Geromini allegedly told investors that “every penny” of their money would be used productively for the company’s development. In reality, the SEC says he diverted more than $200,000 for personal use. He also allegedly misrepresented the company’s cash burn rate and the actual use of proceeds.
The 2021 consent and the 2026 final judgment
Geromini consented to an injunction and an officer-and-director bar in 2021, meaning he agreed not to serve as an officer or director of a publicly traded company. The May 2026 final judgment from the U.S. District Court for the Eastern District of Pennsylvania makes that ban permanent and orders disgorgement of $98,083.
The disgorgement amount is lower than the total amount stolen because the SEC deemed it satisfied by a parallel criminal restitution order. In other words, Geromini was also prosecuted criminally and ordered to pay restitution to his victims. The disgorgement in the civil case will not stack on top of the criminal restitution for the same conduct.
| Defendant | Joseph Geromini |
| Company | Group K Diagnostics / HueDx |
| Alleged misconduct period | August 2018 to May 2019 |
| Amount stolen from investors | More than $200,000 |
| SEC disgorgement ordered | $98,083 (satisfied by criminal restitution) |
| Officer/director bar | Permanent |
| Litigation release | LR-26555 (May 15, 2026) |
Why early-stage startup fraud matters for older investors
Medical device startups are not typical investments for conservative retirees. But the Geromini case illustrates a broader risk that does affect older investors: the startup founder who lies about the use of funds. Similar schemes appear in real estate syndications, REITs, and private placements marketed to accredited investors over 55.
The pattern is consistent. A charismatic executive presents an exciting opportunity. Offering materials look professional. Financial projections show impressive growth. Investors commit capital based on trust and apparent diligence. Then the money disappears, and the executive claims the business simply failed.
In Geromini’s case, the SEC had enough evidence to prove the diversion was intentional rather than mismanagement. The false statements about cash burn rates and the explicit promise that “every penny” would go to the company suggest a deliberate scheme from the start. The criminal prosecution confirms that prosecutors viewed this as theft, not bad business judgment.
How to spot similar misconduct before you invest
Investors can reduce their exposure to this type of fraud by insisting on third-party verification of fund usage. When a startup or private company raises capital, ask whether an independent accountant reviews the books. Request regular financial statements audited by a reputable firm. If the founder resists transparency, that is a red flag.
Also be cautious about companies that rely heavily on projections rather than current revenue. Geromini’s company was an early-stage medical device firm with limited sales. Investors were betting on future commercialization. That is inherently risky. When you combine pre-revenue risk with a founder who controls the cash, the potential for misconduct rises sharply.
Haselkorn & Thibaut fights for investor recovery
Haselkorn & Thibaut represents investors who have lost money to fraud, broker misconduct, and corporate mismanagement. The firm’s partners are former Wall Street defense attorneys who understand the systems that protect wrongdoers and the strategies needed to break through them.
With more than 95 years of combined experience and over $520 million recovered for clients, Haselkorn & Thibaut has built a 98% success rate in investor recovery matters. Robert Thibaut holds an AV Preeminent rating, reflecting the highest level of peer recognition for legal ability and ethical standards. The firm handles cases nationwide and works on a contingency fee basis in many matters.
If you invested in Group K Diagnostics, HueDx, or any similar startup and suspect your funds were misappropriated, contact Haselkorn & Thibaut for a confidential review of your case.
Contact Haselkorn & Thibaut today
Investor recovery cases are time-sensitive. Evidence degrades, statutes of limitations apply, and fraudulent operators often dissipate remaining assets quickly. The sooner you speak with an attorney, the better your chances of recovering losses.
Call 1-888-885-7162 or visit https://htattorneys.com to schedule a consultation with an experienced investor recovery attorney.
Disclaimer: This article is for informational purposes only and does not constitute legal advice. Every case is different, and past results do not guarantee future outcomes.
